BioSpace News Archive

Dicerna Presents PHYOX™2 and Primary Hyperoxaluria Healthcare Utilization Data at American Society of Nephrology (ASN) Kidney Week 2021

Ryvu Therapeutics announced today that it will present new data during the 63rd American Society of Hematology Annual Meeting & Exposition, being held on December 11 – December 14, 2021, in Atlanta and at the 44th Annual San Antonio Breast Cancer Symposium (SABCS) being held on December 7 – December 10, 2021.

Novartis today announced that a Phase II study of investigational iptacopan (LNP023) – a first-in-class, oral, selective factor B inhibitor – in patients with C3 glomerulopathy (C3G) met primary endpoints in both patient cohorts1.

Spirovant Sciences today presented SP-101, an investigational novel recombinant adeno-associated virus (AAV) gene therapy selected for its tropism to human airway epithelia, at the 2021 North American Cystic Fibrosis Conference

Caladrius Biosciences, Inc. provides a corporate update and reports financial results for the three and nine months ended September 30, 2021.

Global Blood Therapeutics, Inc. reported financial results for the third quarter ended September 30, 2021 and recent business progress.

Y-mAbs Therapeutics, Inc. a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer, reported financial results for the third quarter of 2021.

NextCure, Inc. announced that new data from two research studies will be presented during oral and poster sessions at the 63rd annual American Society of Hematology annual meeting, to be held in Atlanta, Georgia and in a virtual platform on December 11-14, 2021.

Athenex, Inc. announced data from the ANCHOR Phase 1 study of KUR-502 to be highlighted in a poster presentation at the 63rd American Society of Hematology Annual Meeting and Exposition, being held from December 11th to December 14th, 2021.

BioLineRx Ltd., a late clinical-stage biopharmaceutical Company focused on oncology, announced an oral presentation and three poster presentations at the 63rd American Society of Hematology Annual Meeting & Exposition, which is being held December 11-14, 2021 in Atlanta, GA, and virtually.